Cellular responses of HPV-positive cancer cells to genotoxic anti-cancer agnets: Repression of E6/E7-oncogene expression and induction of apoptosis

International Journal of Cancer

Volumn 68, Issue 4, 1996, Pages 506-513

  Butz, Karin ^a   Geisen, Caroline ^a   Ullmann, Angela ^a   Spitkovsky, Dimitry ^a   Hoppe Seyler, Felix ^a  

^a GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; DACTINOMYCIN; MITOMYCIN C;

APOPTOSIS; ARTICLE; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; GENOTOXICITY; HUMAN; HUMAN CELL; PAPILLOMA VIRUS; PRIORITY JOURNAL; TUMOR CELL LINE; TUMOR SUPPRESSOR GENE; UTERINE CERVIX CARCINOMA; VIRUS ONCOGENE;

APOPTOSIS; CISPLATIN; CYCLIN-DEPENDENT KINASE INHIBITOR P21; CYCLINS; DNA DAMAGE; DNA-BINDING PROTEINS; FEMALE; HUMANS; MITOMYCIN; ONCOGENE PROTEINS, VIRAL; ONCOGENES; REPRESSOR PROTEINS; TUMOR CELLS, CULTURED; UTERINE CERVICAL NEOPLASMS;

EID: 0029849578     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19961115)68:4<506::AID-IJC17>3.0.CO;2-2     Document Type: Article

References (33)

1. BUTZ, K., SHAHABEDDIN, L., GEISEN, C., SPITKOVSKY, D., ULLMANN, A. and HOPPE-SEYLER, F., Functional p53 protein in human papillomavirus-positive cancer cells. Oncogene, 10, 927-936 (1995).
2. CAELLES, C., HELMBERG, A. and KARIN, M., p53-dependent apoptosis in the absence of transcriptional activation of p53-target genes. Nature (Lond.), 370, 220-223 (1994).
3. DARZYNKIEWICZ, Z., LI, X. and GONG, J., Analysis of DNA content and cyclin protein expression in studies of DNA ploidy, growth fraction, lymphocyte stimulation, and the cell cycle. Meth. Cell Biol., 41, 15-38 (1994).
4. DOWHANICK, J.J., MCBRIDE, A.A. and HOWLEY, P.M., Suppression of cellular proliferation by the papillomavirus E2 protein. J. Viral., 69, 7791-7799 (1995).
5. 1 arrest and apoptosis. Cancer Res., 54, 1169-1174 (1994).
6. EL-DEIRY, W.S., TOKINO, T., VELCULESCU, V.E., LEVY, D.B., PARSONS, R., TRENT, J.M., LIN, D., MERCER, W.E., KINZLER, K.W. and VOGELSTEIN, B., WAF1, a potential mediator of p53 tumor suppression. Cell, 75, 817-825 (1993).
7. FRITSCHE, M., HAESSLER, C. and BRANDNER, G., Induction of nuclear accumulation of the tumor-suppressor protein p53 by DNA-damaging agents. Oncogene, 8, 307-318 (1993).
8. GAVRIELI, Y., SHERMAN, Y. and BEN-SASSON, S.A., Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J. cell. Biol., 119, 493-501 (1992).
9. HAFFNER, R. and OREN, M., Biochemical properties and biological effects of p53. Curr. Opin. genet. Devel., 5, 84-90 (1995).
10. HAUPT, Y., ROWAN, S., SHAULIAN, E., VOUSDEN, K.H. and OREN, M., Induction of apoptosis in HeLa cells by trans-activation-deficient p53. Genes Devel., 9, 2170-2183 (1995).
11. HEMSTRÖM NILSSON, C., BAKOS, E., PETRY, K.-U., SCHNEIDER, A. and DÜRST, M., Promoter usage in the E7 ORF of HPV HPV16 correlates with epithelial differentiation and is largely confined to low-grade genital neoplasia. Int. J. Cancer, 65, 6-12 (1996).
12. HOPPE-SEYLER, F. and BUTZ, K., Repression of endogenous p53 transactivation function in HeLa cervical carcinoma cells by human papillomavirus type 16 E6, human mdm-2, and mutant p53. J. Virol., 67, 3111-3117 (1993).
13. HOPPE-SEYLER, F. and BUTZ, K., Molecular mechanisms of virus-induced carcinogenesis: the interaction of viral factors with cellular tumor suppressor proteins. J. mol. Med., 73, 529-538 (1995).
14. HOSKINS, W.J., PEREZ, C.A. and YOUNG, R.C., Gynecologic tumors. In: V.T. deVita, Jr., S. Hellman and S.A. Rosenberg (eds). Cancer principles and practice of oncology (4th ed.), pp. 1152-1163, Lippincott, Philadelphia (1993).
15. HWANG, E.-S., NAEGER, L.K. and DIMAIO, D., Activation of the endogenous p53 growth-inhibitory pathway in HeLa cervical carci noma cells by expression of the bovine papillomavirus E2 gene. Oncogens, 12, 795-803 (1996).
16. JOHNSON, M., DIMITROV, D., VOJTA, P.J., BARRET, C., NODA, A., PEREIRA-SMITH, O.M. and SMITH, J.R., Evidence for a p53-independent pathway for upregulation of SDI1/CIP1/WAF1/p21 RNA in human cells. Mol. Carcinogen., 11, 59-64 (1994).
17. KASTAN, M.B., ONYEKWERE, O., SIDRANSKY, D., VOGELSTEIN, B. and CRAIG, W., Participation of the p53 protein in the cellular response to DNA damage. Cancer Res., 51, 6304-6311 (1991).
18. KESSIS, T.D., SLEBOS, R.J., NELSON, G., KASTAN, M.B., PLUNKETT, B.S., HAN, S.M., LORINCZ, A.T., HEDRICK, L. and CHO, K.R., Human papillomavirus 16 E6 expression disrupts the p53-mediated cellular response to DNA damage. Proc. nat. Acad. Sci. (Wash.), 90, 3988-3992 (1993).
19. LECHNER, M.S., MACK, D.H., FINICLE, A.B., CROOK, T., VOUSDEN, K.H. and LAIMINS, L.A., Human papillomavirus E6 proteins bind p53 in vivo and abrogate p53-mediated repression of transcription. EMBO J., 11, 3045-3052 (1992).
20. LOWE, S.W., Cancer therapy and p53. Curr. Opin. Oncol., 7, 547-553 (1995).
21. MACLEOD, K.F., SHERRY, N., HANNON, G., BEACH, D., TOKINO, T., KINZLER, K., VOGELSTEIN, B. and JACKS, T., p53-dependent and independent expression of p21 during cell growth, differentiation, and DNA damage. Genes Devel., 9, 935-944 (1995).
22. MIETZ, J.A., UNGER, T., HUIBREGTSE, J.M. and HOWLEY, P.M., The transcriptional transactivation function of wild-type p53 is inhibited by SV40 large T antigen and by HPV 16 oncoprotem. EMBO J., 11, 5013-5020 (1992).
23. MIYASHITA, T. and REED, J.C., Tumor suppressor p53 is a direct transcriptional activator of the human bax gene. Cell, 80, 293-299 (1995).
24. OLTVAI, Z.N., MILLIMAN, C.L. and KORSMEYER, S.J., Bcl-2 heterodimerizes in vivo with a conserved homolog, bax, that accelerates programmed cell death. Cell, 74, 609-619 (1993).
25. SCHEFFNER, M., ROMANCZUK, H., MÜNGER, K., HUIBREGTSE, J.M., MIETZ, J.A. and HOWLEY, P.M., Functions of human papillomavirus proteins. Curr. Top. Microbiol. Immunol., 186, 83-99 (1994).
26. SCHEFFNER, M., WERNESS, B.A., HUIBREGTSE, J.M., LEVINE, A.J. and HOWLEY, P.M., The E6 oncoprotein encoded by human papillomavirus types 16 and 18 functions as an ubiquitin-protein ligase in the ubiquitination of p53. Cell, 63, 1129-1136 (1990).
27. SCHNEIDER-GAEDICKE, A. and SCHWARZ, E., Different human human cervical carcinoma cell lines show similar transcription patterns of human papillomavirus type 18 early genes. EMBO J., 5, 2285-2292 (1986).
28. SHEIKH, M.S., LI, X.-S., CHEN, J.-C., SHAO, Z.-M., ORDONEZ, J.V. and FONTANA, J.A., Mechanisms of regulation of WAF1/CIP1 gene expression in human breast carcinoma: role of p53-dependent and independent signal transduction pathways. Oncogene, 9, 3407-3415 (1994).
29. 1 arrest involves pRb-related proteins and is disrupted by the human papillomavirus 16 E7 oncoprotein. Proc. nat. Acad. Sci. (Wash.), 91, 5320-5324 (1994).
30. STRASSER, A., HARRIS, A.W., JACKS, T. and CORY, S., DNA damage can induce apoptosis in proliferating lymphoid cells via p53-independent mechanisms inhibitable by bcl-2. Cell, 79, 329-339 (1994).
31. VON KNEBEL DOEBERITZ, M., OLTERSDORF, T., SCHWARZ, E. and GISSMANN, L., Correlation of modified human papillomavirus early gene expression with altered growth properties in C4-I cervical carcinoma cells. Cancer Res., 48, 3780-3786 (1988).
32. ZHAN, Q., FAN, S., BAE, I., GUILLOUF, C., LIEBERMANN, D.A., O'CONNOR, P.M. and FORNACE, A.J., Induction of box by genotoxic stress in human cells correlates with normal p53 status and apoptosis. Oncogene, 9, 3743-3751 (1994).
33. ZUR HAUSEN, H., Molecular pathogenesis of cancer of the cervix and its causation by specific HPV types. Curr. Top. Microbiol. Immunol., 186, 131-156 (1994).